Track topics on Twitter Track topics that are important to you
Tuyen Ong is joining Nightstar as executive vice president and chief development officer. Ong comes to Nightstar from South Plainfield, NJ-based PTC Therapeutics (NASDAQ: PTCT), where we was chief medical officer. Ong will be based in Lexington, MA, where London-based Nightstar has its U.S. headquarters. The company, which develops treatments for rare congenital retinal diseases, […]
Original Article: Nightstar Brings Tuyen Ong On Board as Chief Development OfficerNEXT ARTICLE
Congenital conditions are those which are present from birth. They include structural deformities or loss of function in organs such as the <!--LGfEGNT2Lhm-->heart, gut or skeletal system. They can be corrected by <!--LGfEGNT2Lhm-->surgery, m...